Abcam Acquires AxioMx for $45,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=979bc256-af2b-46d2-87be-c4e993508155 - Date
11/11/2015 - Company Name
AxioMx - Mailing Address
688 E Main Street Branford, CT 06405 USA - Company Description
AxioMx has developed synthetic recombinant antibody libraries with greater than ten billion unique clones. Diversity in our libraries is restricted to the most variable positions in the complementarity determining regions (CDRs) of natural antibody sequences. - Website
http://www.axiomxinc.com - Transaction Type
M&A - Transaction Amount
$45,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
The life science research tools supplier said Wednesday it has signed an agreement to buy AxioMx on a cash-free/debt-free basis for $20 million upfront with further performance-based payments totaling $25 million.
